These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2272812)

  • 41. Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms.
    Diener HC; Eikermann A; Gessner U; Göbel H; Haag G; Lange R; May A; Müller-Schwefe G; Voelker M
    Eur Neurol; 2004; 52(1):50-6. PubMed ID: 15240983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic treatment of classical and non-classical migraine with metoprolol--a comparison with placebo.
    Andersson PG; Dahl S; Hansen JH; Hansen PE; Hedman C; Kristensen TN; de Fine Olivarius B
    Cephalalgia; 1983 Dec; 3(4):207-12. PubMed ID: 6640652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
    Ramadan NM; Schultz LL; Gilkey SJ
    Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study].
    Grotemeyer KH; Schlake HP; Husstedt IW
    Nervenarzt; 1988 Sep; 59(9):549-52. PubMed ID: 3054595
    [No Abstract]   [Full Text] [Related]  

  • 45. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
    Tfelt-Hansen P; Standnes B; Kangasneimi P; Hakkarainen H; Olesen J
    Acta Neurol Scand; 1984 Jan; 69(1):1-8. PubMed ID: 6367336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet activity and selective beta-blockade in migraine prophylaxis.
    Joseph R; Steiner TJ; Schultz LU; Clifford Rose F
    Stroke; 1988 Jun; 19(6):704-8. PubMed ID: 2897733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of migraine attacks and migraine prophylaxis: recommendations of the German Migraine and Headache Society].
    Diener HC; Brune K; Gerber WD; Göbel H; Pfaffenrath V
    Med Monatsschr Pharm; 1998 Feb; 21(2):30-9. PubMed ID: 9531789
    [No Abstract]   [Full Text] [Related]  

  • 48. A quantification of the placebo response in migraine prophylaxis.
    van der Kuy PH; Lohman JJ
    Cephalalgia; 2002 May; 22(4):265-70. PubMed ID: 12100088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
    Klapper J
    Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study.
    Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H
    Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An extract of Petasites hybridus is effective in the prophylaxis of migraine.
    Grossmann M; Schmidramsl H
    Int J Clin Pharmacol Ther; 2000 Sep; 38(9):430-5. PubMed ID: 11020030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flunarizine in migraine prophylaxis: the clinical experience.
    Schmidt R; Oestreich W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S21-6. PubMed ID: 1726732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Piracetam versus acetylsalicylic acid in secondary stroke prophylaxis. A double-blind, randomized, parallel group, 2 year follow-up study.
    Grotemeyer KH; Evers S; Fischer M; Husstedt IW
    J Neurol Sci; 2000 Dec; 181(1-2):65-72. PubMed ID: 11099714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effectiveness of tolfenamic acid in the prevention of migraine].
    Vaitkus A; Pauza V
    Medicina (Kaunas); 2002; 38(3):296-303. PubMed ID: 12474702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.
    Lipton RB; Stewart WF; Ryan RE; Saper J; Silberstein S; Sheftell F
    Arch Neurol; 1998 Feb; 55(2):210-7. PubMed ID: 9482363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine.
    Mastrosimone F; Iaccarino C; de Caterina G
    J Med; 1992; 23(1):1-16. PubMed ID: 1573338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metoprolol in migraine.
    Ljung O
    Cephalalgia; 1981 Sep; 1(3):142. PubMed ID: 7346181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.